Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone.

Somjen D, Katzburg S, Stern N, Kohen F, Sharon O, Limor R, Jaccard N, Hendel D, Weisman Y.

J Steroid Biochem Mol Biol. 2007 Nov-Dec;107(3-5):238-44. Epub 2007 Jun 27.

PMID:
17659868
2.

Responsiveness to estradiol-17beta and to phytoestrogens in primary human osteoblasts is modulated differentially by high glucose concentration.

Somjen D, Katzburg S, Kohen F, Gayer B, Sharon O, Hendel D, Kaye AM.

J Steroid Biochem Mol Biol. 2006 May;99(2-3):139-46. Epub 2006 Apr 18.

PMID:
16621514
3.

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds.

Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N.

Circulation. 2005 Apr 5;111(13):1666-71. Epub 2005 Mar 28.

4.

Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo.

Somjen D.

Crit Rev Eukaryot Gene Expr. 2007;17(2):115-47. Review.

PMID:
17725484
5.

Mutual interaction of special phytoestrogenic compounds, their synthetic carboxy-derivatives and the less-calcemic vitamin D analog activities in human derived female cultured osteoblasts.

Somjen D, Katzburg S, Sharon O, Posner GH, Jaccard N, Hendel D, Tamir S, Vaya J.

J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):351-7. doi: 10.1016/j.jsbmb.2011.07.003. Epub 2011 Jul 23.

PMID:
21810473
6.

Responsiveness to phytoestrogens in primary human osteoblasts is modulated differentially by a "less-calcemic" analog of 1,25 dihydroxyvitamin D(3): JK 1624F(2)-2 (JKF).

Somjen D, Katzburg S, Kohen F, Gayer B, Sharon O, Hendel D, Posner GH, Kaye AM.

J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):139-46. Epub 2006 Jan 10.

PMID:
16406510
7.

Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.

Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, O'Loughlin PD, Morris HA.

Bone. 2007 Jun;40(6):1517-28. Epub 2007 Mar 2.

PMID:
17395559
8.

Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion.

Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, Stewart PM, Hewison M.

J Am Soc Nephrol. 2002 Mar;13(3):621-9.

9.

Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells.

van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP.

FASEB J. 2006 Nov;20(13):2417-9. Epub 2006 Oct 5.

PMID:
17023519
10.

The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.

Young MV, Schwartz GG, Wang L, Jamieson DP, Whitlatch LW, Flanagan JN, Lokeshwar BL, Holick MF, Chen TC.

Carcinogenesis. 2004 Jun;25(6):967-71. Epub 2004 Jan 16.

PMID:
14729578
11.

The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua.

Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, Hewison M.

Am J Pathol. 2002 Jul;161(1):105-14.

12.

25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.

Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M.

Biochem Biophys Res Commun. 2001 Jul 27;285(4):1012-7.

PMID:
11467853
13.

Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets.

Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):121-5.

PMID:
15225758
14.

The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus.

St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH.

J Bone Miner Res. 1997 Oct;12(10):1552-9.

15.

Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant.

Flanagan JN, Wang L, Tangpricha V, Reichrath J, Chen TC, Holick MF.

Recent Results Cancer Res. 2003;164:157-67.

PMID:
12899521
16.

1alpha-Hydroxylase and the action of vitamin D.

Hewison M, Zehnder D, Bland R, Stewart PM.

J Mol Endocrinol. 2000 Oct;25(2):141-8. Review.

PMID:
11013342
17.

Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system.

ViganĂ² P, Lattuada D, Mangioni S, Ermellino L, Vignali M, Caporizzo E, Panina-Bordignon P, Besozzi M, Di Blasio AM.

J Mol Endocrinol. 2006 Jun;36(3):415-24.

PMID:
16720713
18.

Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue.

Friedrich M, Diesing D, Cordes T, Fischer D, Becker S, Chen TC, Flanagan JN, Tangpricha V, Gherson I, Holick MF, Reichrath J.

Anticancer Res. 2006 Jul-Aug;26(4A):2615-20.

19.
20.

Expression of 25 hydroxyvitamin D3-1alpha-hydroxylase in human endometrial tissue.

Becker S, Cordes T, Diesing D, Diedrich K, Friedrich M.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):771-5. Epub 2007 Jan 22.

PMID:
17236759

Supplemental Content

Support Center